Ruseva A, Dabbous F, Ding N, Fabricatore A, et al. Semaglutide 2.4 mg long-term clinical outcomes in patients with obesity or overweight: a real-world retrospective cohort study in the United States (SCOPE 12 months). Postgrad Med 2025;137.
PMID: 40122077